Brain metastases arising from prostate cancer are exceedingly rare and generally occur late in the course of the disease. Most patients have widespread metastatic disease before developing brain metastases from prostate cancer. We report the case of an 80-year-old male with adenocarcinoma of the prostate presenting with isolated symptomatic brain metastasis.
Introduction
Prostate cancer commonly metastasizes to the pelvic lymph nodes, axial skeleton, and lungs. [1, 2] Brain metastases from prostate cancer are rare and are usually discovered postmortem. These metastases generally only occur in the context of widespread metastatic disease. It is even more uncommon to have brain as the sole site of the metastatic prostate cancer. We present the case of an 80-year-old male who presented with prostate cancer with isolated brain metastasis.
Case Summary
An 80-year-old male was initially diagnosed with prostate cancer after transrectal ultrasound-guided prostate biopsy following a high prostate-specific antigen value (14 ng/ml). Biopsy revealed adenocarcinoma prostate with Gleason's score of 3 + 4 = 7/10 [ Figure 1 ]. Bone scan revealed no bony metastasis. The patient underwent a bilateral orchiectomy in 2016. In January 2017, the patient developed an episode of generalized tonic-clonic seizure at home and was brought to the emergency department where magnetic resonance imaging brain showed multifocal supratentorial enhancing lesions with mild to moderate perilesional edema, internal heterogeneity, and blooming involving the right frontal lesion suggestive of metastasis [ Figures 2 and 3 ].
Neurology consult was taken and was advised to take a combination of tablet phenytoin 100 mg TID, tablet levetiracetam 500 mg BD, tablet carbamazepine 200 mg BD. The patient improved symptomatically and was discharged on these medications.
Discussion
The antemortem diagnosis of a solitary metastasis to the brain from prostate cancer is exceedingly rare; our review of the literature identified 16 previously reported cases in the literature over the past 25 years. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Survival in these cases generally ranged between 2 and 20 months, In one case, a patient presenting with a right cerebellar infarct following transurethral resection of the prostate 3 months earlier was reported to remain alive and symptom-free 5 years postoperatively following sub-occipital craniotomy with excision of the mass, which was noted to be moderately differentiated adenocarcinoma, and whole brain radiation therapy (WBRT) and radiotherapy to the posterior fossa. [4] For decades, surgical resection with adjuvant WBRT has been the standard of care for solitary metastases in the brain. This combined therapy strategy has been evaluated in randomized studies and found to significantly reduce the risk of recurrence when compared with surgical resection or WBRT alone. The patient got This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. 
Conclusion
Metastatic disease exclusive to the brain in prostate cancer patients remains extremely infrequent. This unique case of an 80-year-old male with an isolated brain metastasis arising from prostate cancer demonstrates that palliative care treatment with antiandrogen and anticonvulsant is effective in managing brain metastasis at his age.
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stable with anticonvulsant medication. He is currently on Tb. Bicalutamide 50 mg OD oral and phenytoin 100 mg THD. He is one regular follow-up. 
